Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Calabresi

Showing results (231-240 of 422) with videos related to

Pageof 43
Sort By:
Acta Neuropathologica Communications|August 2, 2019
Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitisJing Jin, Matthew D Smith, Calvin J Kersbergen, et al.
Neuroimage. Clinical|February 4, 2025
Association of iron deposition in MS lesion with remyelination capacity using susceptibility source separation MRIHyeong-Geol Shin, Woojun Kim, Jung Hwan Lee, et al.
Annals of Clinical and Translational Neurology|October 27, 2021
Measuring treatment response to advance precision medicine for multiple sclerosisPeter A Calabresi, Ludwig Kappos, Gavin Giovannoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2020
Serum ceramide levels are altered in multiple sclerosisAngeliki G Filippatou, Mohammed Moniruzzaman, Elias S Sotirchos, et al.
Glia|September 24, 2017
Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelinationEmily G Baxi, Joseph DeBruin, Jing Jin, et al.
Journal of Neuroimmunology|December 8, 2007
Cleavage of myelin associated glycoprotein by matrix metalloproteinasesElizabeth Milward, Kee Jun Kim, Arek Szklarczyk, et al.
Annals of Neurology|October 23, 2009
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trialKathleen Hawker, Paul O'Connor, Mark S Freedman, et al.
Neuroimage. Clinical|May 20, 2020
TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple SclerosisAlessandra M Valcarcel, John Muschelli, Dzung L Pham, et al.
Neurology|May 3, 2014
Retinal architecture and mfERG: Optic nerve head component response characteristics in MSZane S Schnurman, Teresa C Frohman, Shin C Beh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2014
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCEBernd C Kieseier, Douglas L Arnold, Laura J Balcer, et al.
Pageof 43

Showing results (231-240 of 422) with videos related to

Sort By:
Pageof 43
Acta Neuropathologica Communications|August 2, 2019
Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitisJing Jin, Matthew D Smith, Calvin J Kersbergen, et al.
Neuroimage. Clinical|February 4, 2025
Association of iron deposition in MS lesion with remyelination capacity using susceptibility source separation MRIHyeong-Geol Shin, Woojun Kim, Jung Hwan Lee, et al.
Annals of Clinical and Translational Neurology|October 27, 2021
Measuring treatment response to advance precision medicine for multiple sclerosisPeter A Calabresi, Ludwig Kappos, Gavin Giovannoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2020
Serum ceramide levels are altered in multiple sclerosisAngeliki G Filippatou, Mohammed Moniruzzaman, Elias S Sotirchos, et al.
Glia|September 24, 2017
Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelinationEmily G Baxi, Joseph DeBruin, Jing Jin, et al.
Journal of Neuroimmunology|December 8, 2007
Cleavage of myelin associated glycoprotein by matrix metalloproteinasesElizabeth Milward, Kee Jun Kim, Arek Szklarczyk, et al.
Annals of Neurology|October 23, 2009
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trialKathleen Hawker, Paul O'Connor, Mark S Freedman, et al.
Neuroimage. Clinical|May 20, 2020
TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple SclerosisAlessandra M Valcarcel, John Muschelli, Dzung L Pham, et al.
Neurology|May 3, 2014
Retinal architecture and mfERG: Optic nerve head component response characteristics in MSZane S Schnurman, Teresa C Frohman, Shin C Beh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2014
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCEBernd C Kieseier, Douglas L Arnold, Laura J Balcer, et al.
Pageof 43